Sunday, June 21, 2009
|
Monday, June 22, 2009 |
| 09:00-10:35 |
Epidemiology and Natural History of PSC
Chairs: Erik Schrumpf, Norway
Ulrich Beuers, The Netherlands |
| 09:00 |
Welcome/introduction
Erik Schrumpf, Norway |
| 09:10 |
Update on the epidemiology of PSC
Paul Angulo, USA |
| 09:30 |
PSC in children
Dennis Black, USA |
| 09:55 |
PSC in low-prevalence areas
Carlo Selmi, Italy |
| 10:15 |
Small-duct PSC
Einar Björnsson, Sweden |
| 10:35-11:15 |
Coffee Break and Poster Viewing |
| 11:15-13:00 |
Pathogenesis of PSC I
Chairs: Michael Trauner, Austria
Pietro Invernizzi, Italy |
| 11:15 |
Pathogenesis of PSC
Michael P. Manns, Germany |
| 11:45 |
Genetic epidemiology of PSC
Tom H. Karlsen, Norway |
| 12:10 |
Aberrant lymphocyte homing in PSC – only a hypothesis?
David Adams, UK |
| 12:30 |
Pathogenesis of IBD in PSC
Arthur Kaser, Austria |
| 13:00-14:00 |
Lunch and Poster Viewing |
| 14:00-15:30 |
Pathogenesis of PSC II
Chairs: David Adams, UK
Steve Pereira, UK |
| 14:00 |
Relevance of mouse models in PSC
Peter Fickert, Austria |
| 14:20 |
Role of bile acids in inflammation and carcinogenesis
Michael Trauner, Austria |
| 14:50 |
Role of cholangiocytes in PSC
Marco Marzioni, Italy |
| 15:10 |
Pathogenesis of bile duct fibrosis and liver cirrhosis in PSC
David Brenner, USA |
| 15:30-16:00 |
Coffee Break and Poster Viewing |
| 16:00-17:25 |
Overlap Syndrome and Autoimmunity in PSC
Chairs: Kirsten Muri Boberg, Norway
George Webster, UK |
| 16:00 |
Innate immune responses in PSC
Christopher Bowlus, USA |
| 16:20 |
Pathogenetic importance of autoantibodies in PSC
Ulrich Spengler, Germany |
| 16:45 |
PSC overlap syndromes
Giorgina Mieli-Vergani, UK |
| 17:05 |
Lessons learnt from IgG4-associated cholangitis
Ulrich Beuers, The Netherlands |
| 18:00-19:30 |
Reception and Tour at Oslo City Hall |
| |
|
Tuesday, June 23, 2009 |
| 08:30-10:45 |
Malignancies in PSC
Chairs: Gregory Gores, USA
Ragnhild Lothe, Norway |
|
08:30 |
Cholangiocarcinogenesis
Gregory Gores, USA |
| 09:00 |
Relevance of NKG2D in inflammatory carcinogenesis
Yenan Bryceson, Sweden |
| 09:25 |
Surveillance and early diagnosis of cholangiocarcinoma
Kirsten Muri Boberg, Norway |
| 09:55 |
Colorectal malignancies in PSC
Annika Bergquist, Sweden |
| 10:15 |
Liver transplantation in cholangiocarcinoma
Julie Heimbach, USA |
| 10:45-11:15 |
Coffee Break and Poster Viewing |
| 11:15-13:30 |
Clinical Practice
Chairs: Peter Jansen, The Netherlands
Martti Färkkilä, Finland |
| 11:15 |
Ursodeoxycholic acid therapy in PSC – who benefits?
Keith Lindor, USA |
| 11:35 |
Endpoints and design of future PSC trials
Roger Chapman, UK |
| 12:00 |
Discussion: Endoscopic treatment in PSC – a critical appraisal
Adolf Stiehl, Germany
Lars Aabakken, Norway |
| 12:30 |
Timing and results of liver transplantation in PSC
Kristian Bjøro, Norway |
| 12:50 |
Pathogenesis, diagnosis and prognosis of recurrent PSC
Andrew K. Burroughs, UK |
| 13:15 |
Concluding remarks
Erik Schrumpf, Norway
|
| 13:30-14:30 |
Lunch |